Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors

被引:1466
作者
Finnin M.S. [2 ]
Donigian J.R. [1 ]
Cohen A. [1 ]
Richon V.M. [3 ]
Rifkind R.A. [3 ]
Marks P.A. [3 ]
Breslow R. [4 ]
Pavletich N.P. [2 ]
机构
[1] Cell. Biochem. and Biophsyics Prog., Mem. Sloan-Kettering Cancer Center, New York
[2] Howard Hughes Medical Institute, Mem. Sloan-Kettering Cancer Center, New York
[3] Cell Biology Program, Mem. Sloan-Kettering Cancer Center, New York
[4] Department of Chemistry, Columbia University, New York
关键词
D O I
10.1038/43710
中图分类号
学科分类号
摘要
Histone deacetylases (HDACs) mediate changes in nucleosome conformation and are important in the regulation of gene expression. HDACs are involved in cell-cycle progression and differentiation, and their deregulation is associated with several cancers. HDAC inhibitors, such as trichostatin A (TSA) and suberoylanilide hydroxamic acid (SAHA), have anti-tumour effects, as they can inhibit cell growth, induce terminal differentiation and prevent the formation of tumours in mice models, and they are effective in the treatment of promyelocytic leukemia. Here we describe the structure of the histone deacetylase catalytic core, as revealed by the crystal structure of a homologue from the hyperthermophilic bacterium Aquifex aeolicus, that shares 35.2% identity with human HDAC1 over 375 residues, deacetylates histones in vitro and is inhibited by TSA and SAHA. The deacetylase, deacetylase-TSA and deacetylase-SAHA structures reveal an active site consisting of a tubular pocket, a zinc-binding site and two Asp-His charge-relay systems, and establish the mechanism of HDAC inhibition. The residues that make up the active site and contact the inhibitors are conserved across the HDAC family. These structures also suggest a mechanism for the deacetylation reaction and provide a framework for the further development of HDAC inhibitors as anti- tumour agents.
引用
收藏
页码:188 / 193
页数:5
相关论文
共 30 条
  • [1] Davie J.R., Chadee D.N., Regulation and regulatory parameters of histone modifications, J. Cell Biochem. (Suppl.), 30-31, pp. 203-213, (1998)
  • [2] Kouzarides T., Histone acetylases and deacetylases in cell proliferation, Curr. Opin. Genet. Dev., 9, pp. 40-84, (1999)
  • [3] Fenrick R., Hiebert S.W., Role of histone deacetylases in acute leukemia, J. Cell. Biochem. (Suppl.), 30-31, pp. 194-202, (1998)
  • [4] Yoshida M., Horinouchi S., Beppu T., Trichostatin A and trapoxin: Novel chemical probes for the role of histone acetylation in chromatin structure and function, Bioessays, 17, pp. 423-430, (1995)
  • [5] Richon V.M., Et al., Second generation hybrid polar compounds are potent inducers of transformed cell differentiation, Proc. Natl. Acad. Sci. USA, 93, pp. 5705-5708, (1996)
  • [6] Pichon V.M., Et al., A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases, Proc. Natl Acad. Sci. USA, 95, pp. 3003-3007, (1998)
  • [7] Cohen L.A., Et al., Inhibition of N-methylnitrosourea-induced tumours by the cytodifferentiating agent, suberanilohydroxamic acid (SAHA), Proc. AACR, 39, (1998)
  • [8] Desai D., El-Bayoumy K., Amin S., Chemopreventive efficacy of suberanilohydroxamic acid (SAHA), a cytodifferentiating agent, against tobacco-specific nitrosamine 4-(methylinitros-amino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in female A/J mice, Proc. AACR, 40, (1999)
  • [9] Struhl K., Histone acetylation and transcriptional regulatory mechanisms, Genes Dev., 12, pp. 599-606, (1998)
  • [10] Taunton J., Hassig C.A., Schreiber S.L., A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p, Science, 272, pp. 408-411, (1996)